Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stronger Biotech, officially known as Shanghai Qiangyao Biotechnology, is a high-tech enterprise specializing in the research, development, and manufacturing of peptides and related biological reagents. The company provides a wide range of services including custom peptide synthesis, antibody preparation, and the production of pharmaceutical intermediates. With a focus on high-purity chemical synthesis and purification technologies, Stronger Biotech serves global pharmaceutical companies, research institutions, and universities. Their product portfolio includes specialized peptides such as isotope-labeled peptides, cyclic peptides, and glycopeptides, supporting drug discovery and life science research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Qiangyao Biotechnology.